orderU8771JLFG01FLASH Gene SynthesisGene5A C and 3 more items

GenScript USA Inc has been awarded a contract by Virginia Commonwealth University with an effective date of August 3, 2026, for a cumulative contract value of $178. The prime contractor will deliver gene synthesis and subcloning services to VCU Procurement. The contract encompasses four line items, including FLASH Gene Synthesis services for two separate gene constructs (Gene 5A C and Gene delta) priced at $89 each, along with two subcloning services bundled with gene synthesis activities. All deliverables are designated for delivery to VCU Procurement in Virginia.

The contract specifications detail the provision of molecular biology services critical to genomic research applications. GenScript USA Inc will provide gene synthesis capabilities utilizing FLASH technology methodology for distinct genetic sequences, complemented by subcloning services that integrate the synthesized genes into appropriate vectors. The line item structure indicates a modular approach to service delivery, with quantified pricing available for the two FLASH Gene Synthesis components. No specific period of performance or annual value is documented in the contract award record beyond the effective award date of August 3, 2026.